Project Grant R21NS139920
Award Date
8/15/24
Completion Date
6/30/26
Dollars Obligated
$652K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68198, USA
Similar Awards
This $1,537,749 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to investigate the molecular mechanisms by which HIV proteins and methamphetamine activate the astrocyte-specific NLRP6 inflammasome, leading to neuroinflammation in the context of HIV-associated neurocognitive disorders. The award, with a project period from July 1, 2024 to April 30, 2029, will support in vitro, ex vivo, and in vivo...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $382,072 to George Washington University to conduct research on epigenetic mechanisms contributing to HIV-associated neurocognitive disorders (HAND). The primary objectives are to: 1) characterize the epigenetic modifications induced by HIV infection and HIV protein...
This federal Project Grant award, valued at $383,750.00, was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The primary objective of the grant is to study the molecular, neuro-immune, and behavioral changes that occur during HIV-associated progressive aging using a long-term humanized mouse model. Key research activities include: Evaluating the impact of HIV latency and antiretroviral therapy (ART) on premature aging and functional...
This $197,345 Project Grant was awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The grant supports research to investigate how the HIV virus uses tunneling nanotubes (TNTs) as a mechanism to propagate infection and cause neurodegeneration within the central nervous system. Key objectives include examining how HIV induces TNT formation, the...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) aims to investigate neuroinflammation and identify molecular markers associated with cognitive impairment in individuals with well-controlled HIV. The $131,922 award, effective August 15, 2024 through May 31, 2029, will support the University of Oklahoma Health Sciences Center Division's research to: 1) map microglia activation states in mouse...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $665,171 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program to the Regents of the University of Minnesota. The 5-year grant, awarded on August 18, 2024, aims to improve understanding of drug exposure in the brain and cerebrospinal fluid (CSF) to optimize treatment for HIV-associated opportunistic infections like cryptococcal and TB...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $788,615.00 to Father Flanagan's Boys' Home to conduct research on the dynamic functional mapping of brain circuits underlying cognitive impairment in Alzheimer's spectrum conditions and HIV-related brain dysfunction. The research aims to quantify oscillatory neural dynamics during...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the therapeutic effects of microglia depletion and repopulation (MGDR) on mitigating hand and neuropsychiatric symptoms in individuals with chronic HIV infection. The $880,000 award to Old Dominion University will fund a 2-year study to: 1) Examine the impact of MGDR on hand and neuropsychiatric symptoms in HIV-transgenic mice, and 2) Explore the underlying mechanisms by which...
This $407,000 Project Grant from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research by the University of Texas Rio Grande Valley (UTRGV) to investigate the relationship between HIV infection and the onset and progression of Alzheimer's disease (AD) using AD mouse models infected with a chimeric HIV strain. The central hypothesis is that HIV may accelerate the development of cognitive decline in AD. The 2-year study will conduct longitudinal behavioral,...
This $498,444 Project Grant award, funded under the Trans-NIH Research Support program (CFDA 93.310) by the National Institutes of Health (NIH) Office of the Director, supports research to investigate the effects of HIV-associated extracellular vesicles on mitochondrial dysfunction and blood-brain barrier disruption in brain microvessels. The research aims to: 1) determine the effects of HIV-free extracellular vesicles on mitochondrial and blood-brain barrier dysfunction in the brain...